Skip to content

Study on the effect of improving cognitive function by Betahistine

Study on the effect of improving cognitive function by Betahistine - Study on the effect of improving cognitive function by Betahistine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000015110
Enrollment
43
Registered
2014-09-10
Start date
2014-09-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia of the Alzheimer type

Interventions

On the first day, subjects receive training of the object recognition behavior task and the paired-associate learning task. On the 8th day, they take Betahistine and take tests of the object recognit

Sponsors

Kyoto University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Informed consent for study participants must be obtained from the subjects themselves 2) Over 20 years old and less than 50 years old (at the time of registration) 3) Normal or corrected vision

Exclusion criteria

Exclusion criteria: 1) Active peptic ulcer, bronchial asthma, pheochromocytoma, Meniere's disease, Meniere's syndrome, vertigo, blood disorders, liver failure, kidney failure, and severe mental illness 2) History peptic ulcer, drug dependence, alcoholism, etc. 3) Administration of the drug within a week before the test 4) Pregnant or being suspected females, breast-feeding, males/females who do not agree to the terms of contraception during the study 5) Drinking a fruit juice containing grapefruit, orange, or apple, between the first day and the 8th day in the test period 6) Participated in the Phase 1 clinical trials of new drug substances and received the drug dosing within four months before the test 7) Seropositive of HBs antigen, HCV antibody, HIV antigen-antibody, syphilis serum (TP antibody, RPR method) 8) History of allergies to food or drugs 9) A person who was judged by investigator as an inappropriate subject of the study

Design outcomes

Primary

MeasureTime frame
To evaluate performance of the object recognition behavior task and the paired-associate learning task

Countries

Japan

Contacts

Public ContactMIZUTA Hiroto

Kyoto University Graduate School of Medicine Department of Psychiatry

hmizuta@kuhp.kyoto-u.ac.jp075-751-4947

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026